|
|
|
40
|
0051F
|
CAPECITABINE 150MG TAB (INP/AHI)
|
CAPECITABINE
|
CAPECITABINE
|
6X10
|
BQ
|
194.20
|
3.24
|
TABLET
|
0
|
TAB
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
42
|
0051M
|
CAPECITABINE 150MG TAB (INP)
|
CAPECITABINE
|
CAPECITABINE
|
10'S
|
BQ
|
15.79
|
1.58
|
TAB
|
230
|
PACK
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2026-04-01
|
|
|
ORAL
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
0111FA
|
ADORA 500MG CAP (INC) CEFADROXIL
|
CEFADROXIL
|
ADORA
|
20'S
|
A
|
8.07
|
0.4037
|
CAP
|
28
|
BOX
|
INC
|
INCEPTA PHARMACEUTICALS LIMITED
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08120604
|
FIRST GEN CEPHALOSPORINS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
FIRST GEN CEPHALOSPORINS
|
|
|
|
|
42
|
0111FA
|
ADORA 500MG CAP (INC) CEFADROXIL
|
CEFADROXIL
|
ADORA
|
20'S
|
A
|
8.26
|
0.41
|
CAP
|
28
|
BLIS
|
INC
|
INCEPTA PHARMACEUTICALS LIMITED
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08120604
|
FIRST GEN CEPHALOSPORINS
|
2026-04-01
|
|
|
ORAL
|
0
|
FIRST GEN CEPHALOSPORINS
|
|
|
|
|
41
|
0113BA
|
CEFAZOL 1G INJ (INC) (BQ)
|
CEFAZOLIN
|
CEFAZOL
|
15ML VIAL
|
BQ
|
14.19
|
14.1897
|
VIAL
|
0
|
VIAL
|
INC
|
INCEPTA PHARMACEUTICALS LIMITED
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
08120604
|
FIRST GEN CEPHALOSPORINS
|
2024-04-01
|
2026-03-31
|
|
IV/IM
|
0
|
FIRST GEN CEPHALOSPORINS
|
|
|
|
|
42
|
0131B
|
AZITHRO EZE 40MG/ML SUSP (INF) AZITHROMYCIN
|
AZITHROMYCIN
|
AZITHRO EZE
|
15ML
|
A
|
4.59
|
0.31
|
ML
|
30
|
BOTT
|
INF
|
INFOCUS REMEDIES PVT
|
RXP
|
RX PRO INC
|
B
|
08121292
|
OTHER MACROLIDES
|
2026-04-01
|
|
|
ORAL
|
0
|
OTHER MACROLIDES
|
|
|
|
|
42
|
0451BW
|
CO TRIMOX EZE 400MG|80MG TAB (INF) SULFAMETHOXAZOLE|TRIMETHO
|
SULFAMETHOXAZOLE|TRIMETHOPRIM
|
CO TRIMOX EZE
|
10X10
|
A
|
7.20
|
0.07
|
TAB
|
56
|
BLIS
|
INF
|
INFOCUS REMEDIES PVT
|
RXP
|
RX PRO INC
|
|
081220
|
SULPHONAMIDES
|
2026-04-01
|
|
|
ORAL
|
0
|
SULPHONAMIDES
|
|
|
|
|
42
|
0481BA
|
METRON EZE 400MG TAB (INF) METRONIDAZOLE
|
METRONIDAZOLE
|
METRON EZE
|
10X10
|
A
|
12.78
|
0.13
|
TAB
|
90
|
BLIS
|
INF
|
INFOCUS REMEDIES PVT
|
RXP
|
RX PRO INC
|
|
083092
|
ANTIPROTOZOALS, MISCELLANEOUS
|
2026-04-01
|
|
|
ORAL
|
0
|
ANTIPROTOZOALS, MISCELLANEOUS
|
|
|
|
|
42
|
0481BB
|
FLAMYD 250MG TAB (INC) METRONIDAZOLE
|
METRONIDAZOLE
|
FLAMYD
|
100'S
|
A
|
7.01
|
0.07
|
TAB
|
90
|
BLIS
|
INC
|
INCEPTA PHARMACEUTICALS LIMITED
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
083092
|
ANTIPROTOZOALS, MISCELLANEOUS
|
2026-04-01
|
|
|
ORAL
|
0
|
ANTIPROTOZOALS, MISCELLANEOUS
|
|
|
|
|
40
|
0582B
|
CYTARABINE 1G INJ (INP/AHI)
|
CYTARABINE
|
CYTARABINE
|
1G VIAL
|
BQ
|
38.46
|
38.46
|
INJECTION
|
0
|
VIAL
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
0631AD
|
METHOTREXATE 2.5MG TAB (INP/AHI)
|
METHOTREXATE
|
METHOTREXATE
|
100'S
|
A
|
12.72
|
0.13
|
TABLET
|
32
|
TAB
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
0633V
|
METHACOR 25MG/ML INJ (INP/AHI) METHOTREXATE
|
METHOTREXATE
|
METHACOR
|
2ML VIAL
|
B
|
8.70
|
8.70
|
INJECTION
|
0
|
VIAL
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
0634M
|
METHOTREXATE 25MG/ML INJ (INP/AHI)
|
METHOTREXATE
|
METHOTREXATE
|
20ML VIAL
|
BQ
|
46.43
|
46.43
|
INJECTION
|
0
|
VIAL
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
06351
|
METHOTREXATE 25MG/ML INJ (INP/AHI)
|
METHOTREXATE
|
METHOTREXATE
|
40ML
|
BQ
|
82.12
|
82.12
|
INJECTION
|
0
|
VIAL
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
06417
|
ACCORD MITOMYCIN 5MG INJ (INP/AAL) MITOMYCIN
|
MITOMYCIN
|
ACCORD MITOMYCIN
|
5MG VIAL
|
BQ
|
203.06
|
203.06
|
INJECTION
|
0
|
VIAL
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AAL
|
A. A. LAQUIS LTD
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
0791Y
|
ADRINOR 1MG/ML IV/IM INJ (INC) ADRENALINE (B)
|
ADRENALINE
|
ADRINOR
|
5X1ML
|
B
|
9.05
|
1.8104
|
AMP
|
60
|
BOX
|
INC
|
INCEPTA PHARMACEUTICALS LIMITED
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
121212
|
ALPHA & BETA ADRENERGIC AGONIST
|
2024-04-01
|
2026-03-31
|
|
IV/IM/SC
|
0
|
ALPHA & BETA ADRENERGIC AGONIST
|
|
|
|
|
40
|
11045
|
ACCORD PROPRANOLOL 80MG TAB (INP/AAL)
|
PROPRANOLOL
|
ACCORD PROPRANOLOL
|
56'S
|
A
|
13.40
|
0.24
|
TABLET
|
150
|
TAB
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AAL
|
A. A. LAQUIS LTD
|
B
|
2424
|
BETA ADRENERGIC BLOCKING AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
40
|
1131FW
|
LIPITAS 10MG TAB (INP/AHI) ATORVASTATIN
|
ATORVASTATIN
|
LIPITAS
|
30'S
|
A
|
3.56
|
0.1187
|
TABLET IMMED
|
|
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2023-03-20
|
2024-03-31
|
Add to Contract as Cat A
|
Oral
|
6
|
HMG-CoA REDUCTASE INHIBITORS
|
2023-01-04
|
|
|
|
41
|
1131GT
|
ATORVASTATIN 10MG TAB (INP)
|
ATORVASTATIN
|
ATORVASTATIN
|
1000'S
|
A
|
35.96
|
0.036
|
TAB
|
30
|
BOTT
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
HMG-CoA REDUCTASE INHIBITORS
|
|
|
|
|
40
|
1132HE
|
LIPITAS 20MG TAB (INP/AHI) ATORVASTATIN
|
ATORVASTATIN
|
LIPITAS
|
30'S
|
A
|
4.32
|
0.144
|
TABLET IMMED
|
30
|
|
INP
|
INTAS PHARMACEUTICALS LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2023-03-20
|
2024-03-31
|
Add to Contract as Cat A
|
Oral
|
6
|
HMG-CoA REDUCTASE INHIBITORS
|
2023-01-04
|
